These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31597566)
1. Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia. Vaquero-Baez M; Díaz-Ruíz A; Tristán-López L; Aviña-Cervantes C; Torner C; Ramírez-Bermúdez J; Montes S; Ríos C BMC Psychiatry; 2019 Oct; 19(1):295. PubMed ID: 31597566 [TBL] [Abstract][Full Text] [Related]
2. Whole saliva and plasma levels of clozapine and desmethylclozapine. Dumortier G; Lochu A; Zerrouk A; Van Nieuwenhuyse V; Colen de Melo P; Roche Rabreau D; Degrassat K J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110 [TBL] [Abstract][Full Text] [Related]
3. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia. Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477 [TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia. Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698 [TBL] [Abstract][Full Text] [Related]
5. Development of a simultaneous analytical method for clozapine and its metabolites in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry with linear range adjusted by in-source collision-induced dissociation. Sato T; Suzuka M; Sato Y; Iwabuchi R; Kobayashi D; Ogura J; Takasaki S; Yokota M; Tsukamoto T; Hayakawa Y; Kikuchi M; Maekawa M; Mano N Biomed Chromatogr; 2021 Jul; 35(7):e5094. PubMed ID: 33599311 [TBL] [Abstract][Full Text] [Related]
6. Another use of silica gel and aqueous eluent for HPLC analysis of clozapine and desmethylclozapine. Coudoré F; Nicolay A; Hoareau M; Eschalier A J Anal Toxicol; 1999; 23(3):195-9. PubMed ID: 10369329 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model. Dal Santo F; Jarratt-Barnham I; González-Blanco L; García-Portilla MP; Bobes J; Fernández-Egea E Eur Neuropsychopharmacol; 2020 Apr; 33():158-163. PubMed ID: 32057590 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients. Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285 [TBL] [Abstract][Full Text] [Related]
9. Assay for quantitation of clozapine and its metabolite N-desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection. Edno L; Combourieu I; Cazenave M; Tignol J J Pharm Biomed Anal; 1997 Oct; 16(2):311-8. PubMed ID: 9408849 [TBL] [Abstract][Full Text] [Related]
10. Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia. Costa-Dookhan KA; Rajji TK; Tran VN; Bowden S; Mueller DJ; Remington GJ; Agarwal SM; Hahn MK Sci Rep; 2021 Jan; 11(1):2004. PubMed ID: 33479273 [TBL] [Abstract][Full Text] [Related]
11. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia. Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379 [TBL] [Abstract][Full Text] [Related]
12. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study. Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574 [TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine. Chang WH; Augustin B; Lane HY; ZumBrunnen T; Liu HC; Kazmi Y; Jann MW Psychopharmacology (Berl); 1999 Jul; 145(1):91-8. PubMed ID: 10445377 [TBL] [Abstract][Full Text] [Related]
14. Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations. Augustin M; Schoretsanitis G; Pfeifer P; Gründer G; Liebe C; Paulzen M Schizophr Res; 2019 Aug; 210():143-148. PubMed ID: 31182321 [TBL] [Abstract][Full Text] [Related]
15. Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo. Lane HY; Chiu CC; Kazmi Y; Desai H; Lam YW; Jann MW; Chang WH Drug Metabol Drug Interact; 2001; 18(3-4):263-78. PubMed ID: 11791889 [TBL] [Abstract][Full Text] [Related]
16. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients. González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043 [TBL] [Abstract][Full Text] [Related]
17. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients. Carrillo JA; Herraiz AG; Ramos SI; Benítez J J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697 [TBL] [Abstract][Full Text] [Related]
18. Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia. Smith RL; Wollmann BM; Kyllesø L; Tran TTA; Tveito M; Molden E J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):43-50. PubMed ID: 34928560 [TBL] [Abstract][Full Text] [Related]
19. Clozapine metabolism rate as a possible index of drug-induced granulocytopenia. Mauri MC; Rudelli R; Bravin S; Gianetti S; Giuliani E; Guerrini A; Orlandi R; Invernizzi G Psychopharmacology (Berl); 1998 Jun; 137(4):341-4. PubMed ID: 9676893 [TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma clozapine/N-desmethylclozapine and changes in basal forebrain-dorsolateral prefrontal cortex coupling in treatment-resistant schizophrenia. Sarpal DK; Blazer A; Wilson JD; Calabro FJ; Foran W; Kahn CE; Luna B; Chengappa KNR Schizophr Res; 2022 May; 243():170-177. PubMed ID: 35381515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]